Singapore General Hospital And Thermo Fisher Scientific Collaborate To Identify The Prevalence Of Asian-Specific Genetic Mutations In Cancer

CARLSBAD, Calif.--(BUSINESS WIRE)--Singapore General Hospital (SGH) and Thermo Fisher Scientific today announced the establishment of a collaborative partnership that will work to identify cancer genetic mutations linked with Asian populations on Thermo Fisher’s Ion Torrent next-generation sequencing (NGS) platform.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC